News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
TB death risk can be predicted at diagnosis using basic vitals, study finds
Indian researchers built a simple calculator using BMI, oxygen levels, and respiratory rate to identify TB patients most likely to die within a year. The tool works in resource-poor settings and could guide early intervention.
Maharashtra Hospitals Face $7K Fines, Jail Time for Refusing Emergency Care
The state government is pushing mandatory emergency treatment rules for private hospitals, but doctors say unclear compensation rules and harsh penalties make compliance impossible. Here's why the standoff matters.
Delhi shuts down Fortis Hospital over patient care failures, fire safety gaps
A district magistrate inquiry found illegal construction, fire safety lapses, and delayed emergency treatment at Fortis Shalimar Bagh. The hospital faces formal action after a stab victim allegedly died following treatment denial.
India plans $16.2B medical tourism push with AI diagnostics standards
Government funding scheme for hospitals will require AI-assisted diagnostics, telemedicine, and interoperable records. Five Regional Medical Hubs launching by FY27 to compete for international patients.
71% of Indians targeted by health scams on social media
A McAfee study of 1,000 adults found social media is the leading platform for health and wellness scams in India, followed by messaging apps and phone calls. Fake celebrity endorsements and AI-generated content are making fraud harder to spot.
MedCity News Surveys Health Leaders on AI and Cybersecurity Plans
MedCity News is collecting responses from directors and above at payers and providers on how they're implementing AI safely. Survey takes minutes; qualified participants get a gift card.
FDA Enables Real-Time Trial Data — But Demands Explainable AI First
The FDA is now monitoring clinical trials as they happen, not months later. AstraZeneca and Amgen are piloting the shift. The catch: every algorithm must show its reasoning or the evidence revolution fails.
81% of clinicians ignore AI tools outside their EHR. Here's why pilots fail at scale.
Healthcare AI delivers accurate insights in pilots but stalls when it scales. The problem isn't the models—it's that AI lives outside the workflows where clinicians actually make decisions.
Novartis bets $105M on Antares cancer drug pipeline
Novartis will pay Antares Pharma $105M upfront to co-develop oncology candidates. The deal pairs Novartis scale with Antares' chemistry platform — here's what investors and biotech practitioners need to know.
Remix takes Passage Bio public via reverse merger in gene therapy bet
Passage Bio, co-founded by gene therapy pioneer Jim Wilson, is going public through a reverse merger with Remix. The deal marks a major shift for a company that once pursued cutting-edge treatments.
US health spending hits $5.7T in 2025 as drug use, not prices, drive costs
Total US health expenditure reached $5.7 trillion in 2025, driven primarily by increased utilization rather than price inflation. GLP-1 prescription drugs are accelerating the trend — here's what it means for budgets.
MIT spinout Tissium lands $68M for nerve repair rollout
Tissium secured up to $68M from investors and the European Investment Bank to accelerate U.S. launch of Coaptium, its sutureless nerve repair technology. The MIT spinout aims to expand access to the platform across clinical settings.